AJ-CISATRACURIUM DIN 02408856
Status: Cancelled Pre Market
Holder: AGILA JAMP CANADA INC
Molecule: CISATRACURIUM (CISATRACURIUM BESYLATE)
Health Canada record
| Active ingredient(s) | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M03AC11 CISATRACURIUM |
| Original market date | |
| Current status date | 03-Nov-2015 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CISATRACURIUM (CISATRACURIUM BESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02423782 | CISATRACURIUM BESYLATE INJECTION MULTI-DOSE | FRESENIUS KABI CANADA LTD | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved |
| 02423774 | CISATRACURIUM BESYLATE INJECTION SINGLE DOSE | FRESENIUS KABI CANADA LTD | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved |
| 02563266 | CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE | STERIMAX INC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Marketed |
| 02408813 | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE | OMEGA LABORATORIES LIMITED | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Marketed |
| 02557665 | CISATRACURIUM BESYLATE INJECTION, USP MULTI-DOSE | HIKMA CANADA LIMITED | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved |
| 02408848 | AJ-CISATRACURIUM | AGILA JAMP CANADA INC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market |
| 02425718 | CISATRACURIUM BESYLATE INJECTION | PFIZER CANADA ULC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Post Market |
| 02457385 | CISATRACURIUM BESYLATE INJECTION | ACCORD HEALTHCARE INC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market |
| 02406519 | CISATRACURIUM BESYLATE INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market |
| 02406527 | CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE) | MYLAN PHARMACEUTICALS ULC | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market |
| 02408805 | CISATRACURIUM OMEGA SINGLE DOSE | OMEGA LABORATORIES LIMITED | Solution | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Dormant |
| 02229422 | NIMBEX | ABBVIE CORPORATION | Liquid | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Post Market |
| 02229423 | NIMBEX 10MG/ML | ABBOTT LABORATORIES, LIMITED | Liquid | CISATRACURIUM (CISATRACURIUM BESYLATE) 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14560 | 2013-07-22 | Abbreviated New Drug Submission (ANDS) | Administrative licensing agreement between two companies |